Initial treatment for newly diagnosed elderly colorectal cancer patients: patterns of care in Italy and the United States.

Cancer is a major component of health-care expenditures in most developed countries. The costs of cancer care are expected to increase due to rising incidence (as the population ages) and increasing use of targeted anticancer therapies. However, epidemiological analysis of patterns of care may be required prior to empirically well-grounded cost analyses. Additionally, comparisons of care between health-care delivery systems and countries can identify opportunities to improve practice. They can also increase understanding of patient outcomes and economic consequences of differences in policies related to cancer screening, treatment, and programs of care. In this study, we compared patterns of colorectal cancer treatment during the first year following diagnosis in two cohorts of elderly patients from some areas of Italy and the United States using cancer registry linked to administrative data. We evaluated hospital use, initial treatments (surgery, chemotherapy, and radiation), and timeliness of surgery and adjuvant therapy, taking into account patient characteristics and clinical features, such as stage at diagnosis and the cancer subsite. We observed greater use of adjuvant chemotherapy in stage III and IV colon cancer patients and adjuvant therapy in all stages of rectal cancer patients in the US cohort. We found a higher rate of open surgeries in the Italian cohort, a similar rate of hospitalization, but a higher number of hospital days in the Italian cohort. However, in spite of structural differences between the United States and Italy in health-care organization and delivery as well as in data collection, patterns of care and the timing of care in the year after diagnosis are generally similar among patients within stage of disease at diagnosis. Comparative studies of the costs associated with patterns of cancer care will be important for future research.

[1]  C. Compton,et al.  Colon and Rectum , 2012 .

[2]  Karol Sikora,et al.  Delivering affordable cancer care in high-income countries. , 2011, The Lancet. Oncology.

[3]  J. Warren,et al.  End-of-life care for lung cancer patients in the United States and Ontario. , 2011, Journal of the National Cancer Institute.

[4]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[5]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[6]  G. Gatta,et al.  Patterns of care for European colorectal cancer patients diagnosed 1996–1998: A EUROCARE High Resolution Study , 2010, Acta oncologica.

[7]  M. Federico,et al.  Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. , 2010, European journal of cancer.

[8]  E. Elkin,et al.  Cancer's next frontier: addressing high and increasing costs. , 2010, JAMA.

[9]  P. Bach Limits on Medicare's ability to control rising spending on cancer drugs. , 2009, The New England journal of medicine.

[10]  C. Masseria Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment , 2009, The European Journal of Health Economics.

[11]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[12]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[13]  K. Hersey,et al.  Differences between urologists in United States and Canada in approach to bladder cancer. , 2005, Urology.

[14]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Deborah Schrag,et al.  The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.

[16]  F. Berrino,et al.  Colon cancer prevalence and estimation of differing care needs of colon cancer patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  P. Warde,et al.  Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Lamont,et al.  Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[20]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[21]  A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. , 2001, The New England journal of medicine.

[22]  P. Warde,et al.  Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? , 2001, Journal of clinical epidemiology.

[23]  L. Sobin,et al.  Colon and Rectum , 1998 .

[24]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[25]  Adjuvant therapy for patients with colon and rectum cancer. , 1990, Consensus statement. National Institutes of Health Consensus Development Conference.

[26]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[27]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.